Krystal Biotech
KRYS
KRYS
17 hedge funds and large institutions have $35.5M invested in Krystal Biotech in 2018 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
17
Holders Change
+5
Holders Change %
+41.67%
% of All Funds
0.39%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
4
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Geode Capital Management
Boston,
Massachusetts
|
+$542K |
2 |
![]()
JPMorgan Chase & Co
New York
|
+$318K |
3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$154K |
4 |
Millennium Management
New York
|
+$127K |
5 |
BlackRock
New York
|
+$83.4K |
Top Sellers
1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$5.01M |
2 |
HCM
Highbridge Capital Management
New York
|
-$3.43M |
3 |
TCP
Tourbillon Capital Partners
New York
|
-$701K |